Application 202001
- Type
- ANDA
- Sponsor
- TORRENT PHARMS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | TABLET;ORAL | 500MG;EQ 15MG BASE | No | No |
| 002 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | TABLET;ORAL | 850MG;EQ 15MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 13668-280 | Pioglitazone HCL and Metformin HCL | Pioglitazone HCL and Metformin HCL | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-281 | Pioglitazone HCL and Metformin HCL | Pioglitazone HCL and Metformin HCL | Torrent Pharmaceuticals Limited | ANDA | Current |